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The plant hormone auxin is involved in all stages of plant 
development. Aux/IAAs are the transcriptional repressors that bind to 
the Auxin Response Factors (ARFs) to regulate the gene expression 
upon auxin release. Aux/IAA have highly conserved C-terminal 
domains (domains III-IV) that mediate both homotypic and heterotypic 
interactions between Aux/IAA and ARF family proteins. It has been 
known that Aux/IAA and ARF form homo- and hetero-oligomers for 
the transcriptional regulation, but what determines their association 
states is poorly understood. Here I report, to our knowledge, the first 
solution structure of domain III−IV of Aux/IAA17 (IAA17), and 
characterize molecular interactions underlying the homotypic and 
heterotypic oligomerization. The structure exhibits a compact β-grasp 
fold with a highly dynamic insert helix that is unique in Aux/IAA 
family proteins. The insert helix exhibited fast motions in the ps-ns 
time scale from 15N relaxation data, but the amplitude of the motion is 
likely limited to the local neighborhood. IAA17 associates to form a 
heterogeneous ensemble of front-to-back oligomers in a concentration-
dependent manner. IAA17 and ARF5 associate to form homo- or 
hetero-oligomers using a common scaffold and binding interfaces, but 
 
 ii
their affinities vary significantly. The equilibrium dissociation 
constants (KD) for homo-oligomerization are 6.6 μM and 0.87 μM for 
IAA17 and ARF5, respectively, whereas hetero-oligomerization reveals 
a ∼10- to ∼100-fold greater affinity (KD = 73 nM). Thus, individual 
homo-oligomers of IAA17 and ARF5 spontaneously exchange their 
subunits to form alternating hetero-oligomers for transcriptional 
repression. Oligomerization is mainly driven by electrostatic 
interactions, so that charge complementarity at the interface determines 
the binding affinity. The heterotypic association between ARF1 
repressor and Aux/IAA17 was weaker than individual homotypic 
associations, in contrast to the preferred heterotypic association 
between ARF5 and Aux/IAA17. This finding suggests that ARF 
repressors do not respond to auxin, simply competing with ARF 
activators for binding to the auxin response element. Selective binding 
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Auxin is a major plant hormone that is involved morphogenetic regulation 
of the plant development (1, 2). Aux/IAA and auxin response factors (ARFs) 
regulate the expression of auxin response genes (3). Phylogenetic analysis of 
the Aux/IAA and ARF families has shown that both are represented by 
multiple members in most plants studies (22, 23, 24). The Arabidopsis 
thaliana genome encodes 29 IAA and 23 ARF proteins (22). There are two 
types of transcription regulators for mediate transcriptional responses to auxin 
(4). ARFs (auxin response factor) regulate activation or repression of auxin-
responsive genes expression (5). Aux/IAAs regulate transcriptional repressor 
for regulation ARF (7-9). (Figure 1 A)  
ARF transcription factors contain a DNA-binding domain (DBD) that 
recognizes the auxin-response cis element (AuxREs), cis-regulatory 
sequences that at their core contain a TGTC motif that is sufficient to recruit 
ARF proteins (10). A middle region (MD) that followed by DBD mediates 
transcriptional regulation. ARF protein can be group into two classes from the 
Arabidopsis, depends on which rich residues are contained in the middle 
region (4). Activators of ARF are comprised with glutamine (Q), serine (S) 
and leucine (L)- rich middle region that is based on transient gene expression 
assays in protoplasts. The remaining ARFs are classified as repressor that is 
usually enriched in serine (S) and some case of proline (P), leucine (L) and 
glycine (G) (4). Most ARFs (exclude ARF3, ARF23 and ARF17) has a C-
terminal domain III-IV (Figure 1 A), which is important for the interaction 
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between ARFs and Aux/IAA proteins (8,11). Domain III-IV of ARFs that 
mediates protein-protein interactions with IAA. The C-terminal domains 
III-IV exhibit high sequence homology across the IAA and ARF family 
proteins, and promote both their homotypic (IAA-IAA or ARF-ARF) and 
heterotypic (IAA-ARF) association (8,11). It has been suggested that the 
association of domain III-IV between IAA and ARF is responsible for the 
resultant transcriptional repression. 
Aux/IAA contains 4 domains, domain I interacts with TPL (TOPLESS) 
protein that is co-repressor for transcriptional regulation (15). Domain II that 
followed by domain I mediates the interaction with TIR1 (F-box protein) for 
degradation under high-auxin condition (Figure 1 C) (16). The domain III-IV 
(PB domain) together mediate protein-protein interaction with domain III-IV 
(PB domain) of ARF for inhibits transcriptional activity (Figure 1 B) (8,17).  
In the absence of auxin, IAA associates with ARF and represses its 
transcriptional activity. When auxin is released, IAA interacts with the F-box 
protein Transport Inhibitor Response 1 (TIR1) that assembles into an 
SKP1-Cullin-F-box-type E3 ligase complex that causes IAA degradation 
(13,14). Elevated auxin levels are thus detected by reductions in cellular IAA 
levels, resulting in inhibition of ARF-mediated gene expression.  
Although the interaction between IAA and ARF is of great biological 
significance, a detailed structural characterization of domain III-IV has been 
hampered owing to its aggregative tendency to form heterogeneous oligomers. 
Previous analysis of multiple sequence alignments predicted a structural link 
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between domains III-IV and the Phox and Bem 1 (PB1) domain (18). The 
PB1 domain, a protein interaction module involved in diverse biological 
processes, forms a heterodimer in a front-to-back manner via well-conserved 
acidic and basic residues at the interfaces (19). The essential residues at the 
dimer interface of PB1 were highly conserved in domain III-IV of IAA and 
ARF family proteins, suggesting that they are important for oligomerization. 
Indeed, mutation of the conserved residues has recently allowed for 
determination of the crystal structure of domain III-IV in ARF family 
proteins (20, 21).  In Arabidopsis thaliana, approximately half of the 
Aux/IAA family proteins contain a long insert sequence between the domain 
III and the domain IV, whereas none of the ARF family proteins carries the 
insert sequence (Figure 3, Figure 10).
 
The structures of the domain III−IV are 
similar between PsIAA4 and ARF5 and ARF7 and Aux/IAA17 (27, 25, 26), 
except for the insert region. The function of insert sequences is not yet 
discovered.     
The domain III-IV interaction between ARF and Aux/IAA protein is 
important to define their unique biological functions. Several study suggested 
on combinatorial protein-protein interaction between Aux/IAA and ARF that 
are based on qualitative analysis (Y2H, full-down assay, co-expression and 
sequence homology) (28-32). Most of these studies show similar results ARF 
activator and AUX/IAA, however the binding between Aux/IAA and ARF 
repressor is unclear (28-32). 
Here, I report for the first time the solution structure of domain III-IV of 
Arabidopsis IAA17, and characterize the molecular interactions involved in 
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its homotypic and heterotypic association. IAA17 adopts a compact b-grasp 
fold with a highly dynamic helix that appears to be unique amongst the IAA 
family proteins. I employed the site-directed spin-labeling for the 
paramagnetic relaxation enhancements (PRE) to probe the amplitude of the 
motion of the dynamic helix. Based on the fact that PRE by the nitroxide spin 
label can be observed at distances up to 27 Å, the motion of the αI' helix was 
qualitatively examined. Two residue (C148, C162) spin-labeled by MTSL 
(Figure 11).  
The binding thermodynamics reveal a higher affinity for the IAA17-ARF5 
(activator) heterodimer than for individual homodimers. The binding 
thermodynamics reveal a higher affinity for the ARF1-ARF1 (repressor) 
homodimer than for heterodimers. Based on structural and thermodynamic 
analyses, I propose a working model for transcriptional control that 
Aux/IAA17 with ARF5 (activator) and ARF1 (repressor) selective interaction 












Figure 1. Model of auxin signal transduction.  
 
(A) Schematic representation of Auxin Response Factors (ARFs) and Aux/IAA 
structures. The ARF composed four domains: DNA binding domain (DBD), 
middle region (MR), and III/IV (protein dimerization domain) are colored by 
green and blue. The Aux/IAA sequence motifs domain I (TOPLESS 
interaction), domain II (degron), and domain III/IV (protein dimerization 
domain) are colored by red. Activation or repression of auxin response 
transcription depends on ARF middle domain amino-acid composition.  
 
(B) In low auxin concentrations, Aux/IAA proteins are dimerised with ARF 
proteins, thereby repressing their action.  
 
(C) In high local concentrations, TIR1/AFB perceives auxin. Aux/IAA 



































Materials and Methods 
1. Sample preparation.  
i) Cloning & mutation 
IAA17III-IV (G109-L217), ARF5III-IV (T789-G885) and ARF1III-IV 
(S538-N634) were cloned into a pET28a vector (Merck Millipore) with an N-
terminal His6 tag. Mutations were introduced to generate monomeric proteins: 
K114M for IAA17M1, D183N/D187N for IAA17M2, K797M for ARF5M1, and 
D847N/D851N for ARF5M2, K541A for ARF1M1, D591N/D595N for ARF1M2 
and K541A D591N/D595N for ARF1M3. IAA17M2 was used for structure 
calculation and dynamics using MMR spectroscopy. ARF5M2 and ARF1M3 
were used for backbone assign and dynamics using MMR spectroscopy.  
Cystein mutations were introduced to generate for spin labeling for IAA17 M2: 
Phe148Cys (IAA17M2 F148C) and Phe162Cys (IAA17M2 F162C) mutations were 
introduced into the D183N/D187N construct (the construct that produced a 
monomeric protein) for Aux/IAA17. Cysteine residues were further mutated 
into alanine or serine residues for calorimetry to avoid the use of reducing 
agents. The cysteine position is the C203A mutation was introduced into 
IAA17III-IV, and C825S/C866S/C869S into ARF5III-IV and 
C539S/C560S/C608S into ARF1III-IV. Site-directed mutagenesis was 
performed using the QuikChange Kit (Agilent Technology, Inc.), and the new 







ii) Overexpression & purification 
The plasmids were introduced into Escherichia coli strain BL21-
CodonPlus(DE3)-RIL (Agilent Technology, Inc.) for expression. Transformed 
cells were grown in Luria Bertani or minimal media (with 15NH4Cl and/or 
13C6-glucose as the sole nitrogen or carbon sources, respectively). Protein 
expression was induced by 1 mM isopropyl-D-thiogalactopyranoside at an 
A600 of 0.6~0.8, and the cells were harvested by centrifugation after 5 h of 
induction. The pellet were resuspended in 50 mL (per liter of culture) of 20 
mM Tris, pH 7.4, 200 mM NaCl, 2 mM b-mercaptoethanol, 1 mM 
phenylmethylsulfonyl fluoride, lysed using Emulsiflex C3 (Avestin, Canada), 
and centrifuged at 25,000 ´ g for 20 min. The supernatant fraction was loaded 
onto a HisTrap HP column (GE Healthcare), and the fusion protein was eluted 
with a 100-ml gradient of imidazole (15-500 mM). Fractions containing the 
protein were identified by SDS-polyacrylamide gel electrophoresis. The 
fusion protein was then dialyzed against 20 mM Tris, pH 8.0, 100 mM NaCl, 
and 2 mM b-mercaptoethanol, and the His6 tag was cleaved by TEV protease. 
The digestion reaction was loaded onto the HisTrap column. The protein was 
further purified by size exclusion chromatography using a HiLoad Superdex 
75 column (GE Healthcare) and then by anion exchange chromatography 
using a monoQ column (GE Healthcare). All protein samples were finally 






2. NMR spectroscopy.  
NMR spectra were recorded at 25°C on Bruker 600, 700, 800, 900 MHz 
spectrometers equipped with a z-shielded gradient triple resonance probe. The 
NMR sample contained 1 mM 13C,15N-IAA17M2, 0.7mM 
13C,15N-ARF5M2, 
0.7mM 13C,15N-ARF1M3 in 10 mM sodium phosphate, pH 7.4, and 4 mM 
EDTA . Sequential and side chain assignments of 1H, 15N, and 13C resonances 
was achieved by three-dimensional triple resonance through-bond scalar 
correlation experiments (CBCACONH, HNCACB, HBHA(CO)NH, HNCO, 
HN(CA)CO, HCCH-TOCSY, and 15N-TOCSY-HSQC). Three-dimensional 
13C-separated NOESY and 15N-separated NOESY experiments were obtained 
using the mixing time of 120 ms. Residual 1DNH dipolar couplings were 
obtained by taking the difference in the J splitting values measured in oriented 
(6.5% neutral gel alignment medium) and isotropic (water) media using 2D 
in-phase/antiphase 1H-15N HSQC spectrum (33). 15N-R1 and 
15N-R2 relaxation, 
and 1H-15N heteronuclear NOE measurements were carried out using pulse 
schemes described previously (34). Delays of 10, 20, 50, 100, 400, 800, 1200, 
1500 ms were used for the R1 relaxation measurement, and 17.0, 33.9, 50.9, 
67.8, 101.8, 118.7, 152.6, 203.5 ms were used for the R2 relaxation 
measurement. NMR spectra were processed using the NMRPipe program (35), 
and analyzed using PIPP (36) and NMRView (37) programs. NMR titration 
experiments were recorded at 25°C on a Bruker 600 MHz spectrometer. 
1H-15N HSQC spectra were recorded with 0.2 mM 15N-IAAM1 or 
15N-IAAM2 
titrating stoichiometrically with the partner proteins, and changes in the 
backbone amide chemical shifts were measured. 
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3. MTSL nitroxyl radical labeling 
For PRE measurements, Cysteine mutation of the spin-label, MTSL, was 
conjugated to the Aux/IAA mutants (IAA17M2 F148C, IAA17M2 F162C) via a 
disulfide bond with the cysteine residue (39). The cysteine variants were first 
reduced with 10mM DTT, which was removed using HiPrep desalting 
columns. After DTT removal the protein solution was incubated overnight 
with a 10-fold molar excess of MTSL. After conjugation MTSL, unreacted 
MTSL was removed by passing the monoQ column.   
For the intra-molecular PRE measurements, NMR experiments were recorded 
with 15N-labeled samples containing 10 mM sodium phosphate, pH 7.4, and 4 
mM EDTA buffer at 25°C in 10% D2O, except diamagnetic sample. For 
diamagnetic sample contained same buffer with reducing agent (5mM DTT). 
Contributions of the PRE effect to the relaxation rates are measure by 
detecting line broadening on the 2D-HSQC. We used NMR measurements 
performed on Bruker Avance, and 900MHz. Spectra were processed using 
NMRPipe and analyzed using the program NMRView (38).  
 
4. Structure calculation.  
Interproton distance restraints were derived from the NOE spectra and 
classified into distance ranges according to the peak intensity. f/y torsion 
angle restraints were derived from backbone chemical shifts using the 
program TALOS+ (41). Structures were calculated by simulated annealing in 
torsion angle space using the Xplor-NIH program (40). The target function for 
simulated annealing included a covalent geometry, a quadratic van der Waals 
repulsion potential (42), square-well potentials for interproton distance and 
torsion angle restraints (43), hydrogen bonding, RDC restraints (44), 
harmonic potentials for 13Ca/13Cb chemical shift restraints (45), a 
multidimensional torsion angle database potential of mean force (46), and a 
radius of gyration term (47). The radius of gyration represented a weak 
 
 １０
overall packing potential, and structures were displayed using the VMD-
XPLOR software (48). 
 
 
5. Isothermal titration calorimetry. 
ITC was performed at 25°C using an iTC200 calorimeter (GE Healthcare). 
0.1mM of IAA17M1, ARF5M1 or ARF1M1 was placed in the cell and titrated 
with 1mM IAA17M2, ARF5M2 or ARF1M2. Twenty consecutive 2 μL aliquots 
of protein were titrated into the cell. The duration of each injection was 4 s, 
and injections were made at intervals of 150 s or 180s. The heats associated 
with the dilution of the substrates were subtracted from the measured heats of 
binding. ITC titration data were analyzed with the Origin version 7.0 program 


















Part I. Structure of Aux/IAA17 domain III-IV 
 
Domain design of IAA17, ARF5, and ARF1 
Domain III-IV of wild-type IAA17 (IAA17III-IV) has oligomerization 
pattern in a concentration-dependent manner (Figure 2 A.). Wild type of 
IAA17III-IV made a small set of broad signals owing to the large size and 
chemical exchanges arising from oligomerization in 1H-15N HSQC spectrums 
(Figure 5 A.). I selected highly conserved residues (Lys114 on basic surface 
and Asp183 and Asp187 on the acidic surface) for charge-neutralizing 
mutations, based on the sequence homology between IAA17III-IV and PB1 
domains. A K114M mutation (IAA17M1) or D183N/D187N mutation 
(IAA17M2) resulted in an exclusively monomeric protein manner (Figure 2 B.). 
HSQC spectra of monomeric IAA17M1 and IAA17M2 showed well-dispersed 
signals, which are typically observed in folded proteins (Figure 5 B. C.). The 
mutations of ARF5 that prevented the oligomerization of IAA17III-IV 
produced a monomeric state similarly. A single mutant, K797A (ARF5M1), 
and a double mutant, D847N/D851N (ARF5M2), produced monomeric 
proteins (Figure 2 C.). Based on the sequence homology between ARF1 
domain III IV and ARF5, I mutated K546M in basic interface and D596N, 
D600N in acidic interface. Each protein is elution in monomeric protein based 
on size exclusion chromatography. According to the structure of ARF5 PB 
domain (4chk), the electrostatic interaction is the key interaction in auto-
assembly but hydrogen bonding and hydrophobic contacts also contribute in 
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self-oligomerization(49). The binding interface are present in all ARF 
activator and most Aux/IAA and several residues are also conserved in ARF 
repressor (Figure 3, Figure 21). 
 
Figure 2. Size exclusion chromatograms 
(A) Wild-type IAA17III-IV at variety concentrations. The injection 
concentrations of IAA17III-IV were 400 μM, 200 μM, 150 μM, 50 μM, and 
10 μM. The elution concentration measured by the peak height (103 μM, 50 
μM, 40 μM, 12 μM, and 3 μM).  
(B) IAA17M2 (red),which exist as monomeric protein in solution. Mixing 
IAA17M1 and IAA17M2, results in the formation of a dimer (mixed in a 1: 1.5 
ratio, (black)).  



















Figure 3. Multiple sequence alignment of IAA and ARF family (A. 
thaliana) using ClustalW.  In the sequence alignment, highly conserved 
Lys114 at the positive surface, and Asp183 and Asp187 at the negative surface are 
shaded in orange and blue. Sequences of ARF3, ARF13, and ARF17 are less 










































































































































Figure 4. Structure of Aux/IAA17 DIII-IV, ARF5 DIII-IV, and 
ARF1 DIII-IV monomers 
Conserved basic and acidic residues of the canonical type I/II PB1 features 
are presented as blue and red spheres. (A) Aux/IAA17 DIII-IV (2MUK) (B) ARF5 










































 1H-15N HSQC spectra of (A) wild-type 15N -IAA17III-IV, (B) 
15N -IAA17M1, and (C) 
15N - IAA17M2 in 10 mM sodium phosphate, pH 





























































Structure and dynamics of IAA17III-IV 
Structure was determined the solution structure of the 13C-15N 
isotope-labeled IAA17M2, which comprise amino acid residues 106-217 
(Domain III-IV) and D183N, D187N (for monomeric state), by using NMR 
spectroscopy. Standard 3D NMR spectra [HNCACO, HNCACB, HNCO, 
HN(CO)CACB, CBCACONH] were analyzed for the assignment of backbone 
of IAA17M2 (Figure 6). Backbone and side chain assignments were obtained 
using heteronuclear correlation spectroscopy of three-dimensional. Three-
dimensional 13C-separated NOE and 15N-separated NOE restraints were used 
for the structure calculation using the Xplor-NIH program (40). Residual 
dipolar couplings (RDCs) of IAA17M2 were measured in 6.5% neutral gel 
alignment medium. The structure was determined by using 2,141 NMR 
restraints including 1,858 experimental NOE restraints, 183 dihedral angle 
restraints, 51 backbone 1DNH RDC restraints, and 49 hydrogen bonding 
restraints. Experimental constraints and structure statistics of IAA17M2 are 
summarized in Table 1. 
 
The 20 lowest-energy refined structures of IAA17M2 (out of 100 
structures) are well defined and converges with a backbone (Figure 7 A). A 
ribbon diagram of the lowest energy structure is shown in Figure 7 B and The 
main residue of charge-charge interactions, K114 is colored by orange, D183 
D187 are colored by blue. IAA17M2 is comprised of five b strands and four a 
helices, which adopts a canonical PB1-like b-grasp fold with slight 
modifications. The backbone structures of IAA17M2 atoms ensemble the final 
20 simulated annealing structures (Figure 7 A). The secondary structures are 
 
 １８
well ordered except for the a1' and a3 helices (Figure 7 A B). The N-terminal 
domain III region forms an antiparallel b sheet (b1-b2) and a1. Domain IV 
region consists of a b3-b4-a2-b5-a3 fold as an antiparallel b sheet. b1 of 
domain III and b5 of domain IV form a parallel b sheet, joining the two 
domains into a compact b-grasp fold (Figure 7 B). The conserved residues 
Asp183 and Asp187 are located on the loops flanking b4. The position of the 
other conserved lysine (K114) is on the surface-exposed face of b1 (Figure 7 
B). The overall structural architecture of IAA17M2 is similar to the domain 
III-IV of ARF5 (ARF5III-IV), ARF7 (ARF7III-IV), and pIAA4 (IAA4 III-IV) 
except for the a1' helix in IAA17M2 (Figure 7 C–D)(25-27).  
Long insert sequence is contained half of the IAA family protein in 
Arabidopsis thaliana, which varies in lengths and amino acid compositions. 
None of the ARF family protein carries this a1' helix (insert sequence) 
(Figure 10, Figure 3). Particularly, IAA17 contains the longest insert sequence 
with more than 15 extra residues in IAA family. Based on 15N relaxation data 
from the backbone amide groups, most of the a1' helix manifested fast 
motions in the picosecond to nanosecond time scale. 1H-15N heteronuclear 
NOE data also reduced, and it indicates that the the a1' helix and its preceding 
loop were highly mobile (Figure 9). 
To figure out how dynamic a1' helix affects to the folding of IAA, I 
mutated IAA17M2 (D159-169) that removed the a1' helix. The backbone 
amide chemical shifts mostly located same position, when the HSQC spectra 
were compared between IAA17M2 and IAA17M2 (D159-169), except for the 
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missing residues from the a1' helix (Figure 8). This result represents that 
IAA17III-IV adopts the same b-grasp scaffold without the insert helix.  
 
Figure 6. Backbone assignment of Aux/IAA17 Domain III-IV 
The 1 H-15N HSQC spectrum of Aux/IAA17 domain III-IV was measured at 600 MHz, 
in 10 mM sodium phosphate, pH 7.4, at 25℃. Each cross-peak corresponding to the 
backbone chemical shift information of an individual amino acid residue is labeled by 




Table 1. Restraints and structural statistics of IAA17M2 
 
Experimental restraints <SA>* 
Non redundant NOEs 1858 
Dihedral angles, f / y / c 84 / 84 / 15 
Hydrogen bonds 49 
Residual dipolar coupling, 1DNH 51 
Total number of restraints 2141 (19.3 per residue) 
rms deviation from experimental 
restraints 
 
Distances (Å) (1858) 0.053 ± 0.002 
Torsion angles (°) (183) 0.87 ± 0.07 
Residual dipolar coupling R-factor (%)†  
1DNH (%) (51) 2.9 ± 0.5 
rms deviation from idealized covalent 
geometry 
 
Bonds (Å) 0.004 ± 0 
Angles (°) 0.50 ± 0.03 
Impropers (°) 0.51 ± 0.02 
Coordinate precision (Å)*‡  
Backbone 0.48 ± 0.08 
Heavy atoms 0.98 ± 0.17 
Ramachandran statistics (%)‡§  
Most favorable regions 91.5 ± 1.0 
Allowed regions 8.5 ± 1.0 
* For ensemble of the final 20 simulated annealing structures 
† The magnitudes of axial and rhombic components of the alignment tensor were 
-11.5 Hz and 0.55, respectively. 
‡ Residues 112-217, excluding residues 150-178 with internal motions 
§ Calculated using the program PROCHECK (34) 
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Figure 7. Structures of domain III-IV of IAA17, ARF5, and ARF7.  
 
(A) Superposition of the backbone atoms of the final 20 simulated annealing 
structures of IAA17M2.  
(B) Front (left) and top views (right) of the solution structure of IAA17M2 as a 
ribbon diagram representation. The conserved residues Lys114 (blue), 
Asp183 and Asp187 (orange) are shown as a space-filling representation.  
(C) Crystal structure of ARF5IIIIV (PDB ID: 4CHK (25)) 
(D) Crystal structure of ARF7IIIIV (PDB ID: 4NJ7 (26)) as a ribbon diagram 




Figure 8. 1H-15N HSQC of IAA17M2 and IAA17M2 (Del 159-169) 
Superimposed 1H-15N HSQC spectra of 15N-IAA17M2 (black) and 
15N-IAA17M2 (Del 
159-169) (red) in 10 mM sodium phosphate, pH 7.4, at 25℃. The missing amide 
resonances in 15N-IAA17M2 (Del 159-169)due to the truncation of the α1’ helix are 
annotated with residue names and numbers. Amide resonances with chemical shift 





























































































Figure 9. Plots of relaxation parameters of backbone amide groups 
of IAA17M2. (A) 15N R1relaxation, (B) 
15N R2relaxation, and (C) 
1H-15N 
heteronuclear NOE data as a function of residue number. The secondary structures of 











Dynamics of the mobile insert helix in the domain III−IV of Aux/IAA17 
probed by site-directed spin labeling and paramagnetic 
 
15N R2 relaxation rates 
1H−15N heteronuclear NOE measurements 
show that a1’ helix has fast motion in the picosecond to nanosecond time 
scale. To investigate amplitude of a1’ helix motion, I employed site-directed 
spin-labeling and the paramagnetic relaxation enhancements (PRE). Based on 
the fact that PRE by the nitroxide spin label can be observed at distances up to 
27Å, the motion of the α1' helix was qualitatively examine. The position of 
spin-labeled is shown in Figure 11. 
The Spin label MTSL [1-oxy-2,2,5,5-tetramethyl- pyrroline-3-
methyl]-methane-thiosulfonate] was conjugated by surface-engineered 
cysteine residues in the IAA17M2F148C and IAA17M2F162C (Figure 11). 
Based on the three-dimensional solution structure, I designed two single-
cysteine mutants for the introduction of the nitroxide spin label MTSL. The 
position of cysteine mutation was in the αI helix (F148C) and in the α1' helix 
(F162C) as shown in Figure 11.  
The paramagnetic line broadening is measured for to get the motion 
of the α1' helix in the Aux/IAA17 domain III−IV. As the relaxation rate of the 
nuclear magnetization, the signal intensity of the affected nuclei reduces. The 
line width of a proton and nitrogen signal would be significantly perturbed 
when the proton and nitrogen are within 27.0 Å of the paramagnetic MTSL. 
They are fully suppressed when the distance is less than 10.5 Å due to its fast 
transverse relaxation rate (49). 
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I have studied the paramagnetic line broadening of each sample 
(148C, 162C) by using 2D 1H-15N heteronuclear single quantum correlation 
(HSQC) spectra of each Aux/IAA17 mutants, which were prepared spin-
labeling MTSL and unspin-labeling sample. The differential line broadening 
originates in the PRE, and the results show that the intensity of amide across 
peak 1H-15N HSQC spectrum. Because, changes in HSQC cross-peak 
intensities of the spin-labeled Aux/IAA mutants (I) and comparison to unspin-
labeled Aux/IAA mutants (I0) were plotted in a bar graph, as shown in Figure 
12. The bar graph indicates that the most of the residues decrease in cross-
peak intensity, because the total Aux/IAA mutant size are in 20.0 Å (I/ I0<0.6). 
Our result shows that similar patterns of line broadening in Figure 12. 
Complete suppression or low intensity cross-peaks are observed in each spin-
label position. These cross-peaks intensity data indicate the three-dimensional 
distance information that is presented on 3D structure (Figure 13). As 
expected from the structure, 148C-MTSL result shows that suppression peaks 
and low intensity cross-peaks (0.3 <I/Io) are evenly distributed on α1’ (Figure 
12 A). The 162C-MTSL result also shows similar result in α1’ (Figure 12 B). 
the α1’ helix is dynamic in fast time scale motion but the amplitude of motion 
is not likely large (Figure 13).  
 
Figure 10. Multiple sequence aliment of Aux/IAA in Arabidopsis 
 The Arabidopsis thaliana encodes 29 Aux/IAA proteins that contain carboxyl-
terminal domain. These carboxyl-terminal domain conserved Lys (red) for acid face 
and Asp (blue) for basic face. The structure of Aux/IAA17 is similar that domain III-
IV of ARF5, ARF7 and PsIAA4, except for the insert αI' helix between the domains 










Figure 11. Spin label residue on Aux/IAA17 structure  
(A) Front views of the solution structure of Aux/IAA17. The point mutation residues 




















Figure 12. Paramagnetic effect from F148C-MTSL and F162C-MTSL. 
PRE data of Aux/IAA17 Domain III_IV.  
Two Cys-substituted and spin-labeled variants of Aux/IAA DIII_IV, F148C-MTSL, F162C-
MTSL were analyze via the intensity ratio of the H, N cross-peaks determined. Blank spaces 
in the diagrams are either due to proline (4 residues) or the inability to measure the peak 
height as a consequence of overlapping or non-assigned residues. Fully suppression signal 
of residues are highlighted in red bar on the graph. 
 
Intensity ratio (I/Io) =Intensity of spin labeling Aux/IAA17 Muts / Intensity of Aux/IAA17 
Muts     
Change in peak intensities for residues in Aux/IAA17 upon addition of MTSL, measured as 
a ratio of the intensities of peak in the spin-label state over their corresponding intensities in 
the unlabeled state. 
A. The spin-labeled side chain Aux/IAA17 (F148C). 















Figure 13. Backbone amides with paramagnetic effects in the three-
dimensional structure. 
A. F148C-MTSL (alpha1) spin labeling  
B. F162C-MTSL (alpha1’) spin labeling   
Results are shown on the ribbon diagram and surface of the previously determined 
NMR structure of Aux/IAA17 domain III_IV. The position of the spin-label 
residue is shown in orange and marked by a label. Amides that are broadened to 
undetectable levels are shown in red and light gray. Amides that are broadened 
with measurable intensity ratios > 0.3 are shown in dark gray. White colored 
residues are either overlapped in 
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Part II. Interaction of Aux/IAA 17 domain III-IV 
and ARF5 domain III-IV 
 
 
Interaction between IAA and ARF proteins 
 
Mapping the binding interface of the IAA17 DIII/IV homodimer 
and heterodimer 
In order to compare binding interface of the homodimer and 
heterodimer, I took advantage of NMR titration method. 15N-labeled IAA17M1 
used similar binding interface in the case of IAA17M2 and ARF5M2.  The 
results showed large chemical shift perturbations are mainly in the b3-b4-a2 
region (Figure 14 A, Figure 15 A). The CSP of 15N-labeled IAA17M2 also 
showed similar results. The results showed large chemical shift perturbations 
are mostly in the b2-b1-b5 region that contained K114, when 15N-labeled 
IAA17M2 titrated with IAA17M1 or ARF5M (Figure 14 B, Figure 14 C). These 
similar chemical shift perturbation profiles indicate that IAA17 employed 
similar binding interface for the homodimer formation and for the heterodimer 
formation. 
 In previous study, ARF5III-IV and ARF7III-IV contain an oligomer extended in 
a front-to-back homo-multimerization (25,26). The binding interface of the 
ARF5 DIII-IV oligomer could be mapped on to IAA17III-IV based on 
sequence alignment, and the interfacial residues overlapped with the residues 
that exhibited large chemical shift perturbations. This suggests that the homo-
oligomer of IAA17III-IV and the hetero-oligomer between IAA17III-IV and 
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ARF5III-IV, adopt a similar structural arrangement in the crystal structure 
(ARF5 : 4CHK).  
 
The binding affinity of IAA17DIII/IV homodimer and heterodimer 
To understand the interaction with Aux/IAA and ARF5 (activator) 
through domain III-IV (PB domain), I measured the binding affinities of the 
mutant for the homodimer (IAA17: IAA17, ARF5: ARF5) and the 
heterodimer (IAA17: ARF5) formation by calorimetry and the KD value was 
obtained as 6.6 μM, 0.87 μM, and 75 nM (Figure 16). There are two different 
ways in case of heterodimer, which protein employs the positive interface for 
the complex formation. During the titration experiment of heterodimer, it was 
carried out in both directions. The KD value was 0.87 mM in case of the ARF5 
homodimer formation, 8-fold stronger than that of the IAA17 homodimer 
(Figure 16 B, and Table 2). Respectively, the binding affinity for heterodimer 
was stronger than both homodimers. The KD values were measured as 75 nM 
and 71 nM for IAA17M1:ARF5M2 and ARF5M1:IAA17M2 complexes. (Figure 
12 C–D, and Table 2). As a result, the binding affinity of the homodimer was 
90 times strong than the IAA17 homodimer, and 12 times stronger than the 
ARF5 homodimer. 
Based on the binding affinity of IAA17 mutants, I examined the interaction of 
Wild-type IAA17 for the homodimer (wild-type IAA17: IAA17M1) and (wild-
type IAA17: IAA17M1) (Figure 18). The KD values revealed in 5.9 ± 1.7 μM 
and 5.8 ± 0.9 μM for IAA17 M1 and IAA17M2. This result indicates that 
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mutations introduced into IAA17M1 or IAA17M2 little altered the binding of 
the interaction surface. I examined the binding between wild-type IAA17III-
IV and the mutants at varying concentrations of IAA17III-IV.  
To determine character of the a1' helix, I also measured the mutant 
(IAAM2Del159-169) for the homodimer (IAA17: IAA17) and the heterodimer 
(IAA17: ARF5) formation (Figure 17). The binding affinities for the 
dimerization are little changed regardless of the absence of the a1' helix by 
using an ITC (Figure 17, Table 2). Taken together, our results suggest that the 
insert of a1' helix is not critical for the proper folding of IAA17III-IV, and for 







Figure 14. Homodimer interface of Aux/IAA17 domain III-IV   
Weighted average 1HN/
15N chemical shift perturbation (CSP=([(HN)
2 + 
(N)
2/25]/2)1/2) as a function of residue number upon homodimer 
formation. Residues with  > 0.08 are shown in yellow with the 
conserved Lys114 in blue, and Asp183 and Asp187 in orange as a 
space-filling representation. (A) 15N-IAA17M1 and IAA17M2 (B) 
15N-



















Figure 15. Heterodimer interface of Aux/IAA17 domain III-IV 
Weighted average 1HN/
15N chemical shift perturbation (CSP= ([(HN)
2 + 
(N)
2/25]/2)1/2) as a function of residue number upon heterodimer 
formation between IAA17IIIIV, and ARF5IIIIV. Residues with  > 0.08 
are shown in yellow with the conserved Lys114 in blue, and Asp183 
and Asp187 in orange as a space-filling representation.  
(A) 15N-IAA17M1 and ARF5M2 (B) 




Figure 16. KD of the homodimer and heterodimer formation of 
IAA17IIIIV and ARF5IIIIV. 
Integrated heats of injection (solid squares) and the least squares fit 
curves (black line), derived from a simple one-site binding model for 
the titration between  
(A) IAA17M1 and IAA17M2 (B) ARF5M1 and ARF5M2 (C) IAA17M1 and 















Table 2. Thermodynamic parameters for the homodimer and heterodimer 
formation between of IAA17 domains III-IV and ARF5 domains III-IV 
























Description KD (μM) DG (kcal/mol) DH (kcal/mol) -TDS (kcal/mol) 
IAA17M1 + IAA17M2  6.6 ± 0.3 -7.1 ± 0.0  -9.7 ± 0.1 2.6 ± 0.1 
ARF5M1 + ARF5M2  0.87 ± 0.07 -8.3 ± 0.0 -11.1 ± 0.1 2.8 ± 0.1 
IAA17M1 + ARF5M2 0.075 ± 0.03 -9.7 ± 0.2  -9.3 ± 0.1 -0.4 ± 0.2 
ARF5M2 + IAA17M1 0.071 ± 0.05 -9.8 ± 0.4  -9.5 ± 0.2 -0.3 ± 0.4 
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Figure 17. KD of the homodimer and heterodimer formation of 
IAA17M2(Del159-169) 
Raw ITC data (top panels) and integrated heats of injection (bottom panels) for the 
titration between (A) IAA17M1 and IAA17M2(Del159-169) (B) ARF5M1 and 
IAA17M2(Del159-169). In the bottom panels, squares are the experimental data, and 
solid lines represent the least-squares best fit curves derived from a simple one-site 
binding model.  
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 = 5.5 ± 0.3 mM KD = 64 ± 8.6 nM







































A                               B 
Figure 18. KD of the homodimer and heterodimer formation of wild-
type IAA17 domain III-IV 
Raw ITC data (top panels) and integrated heats of injection (bottom panels) for the 
titration between (A) IAA17M1 and wild-typeIAA17 (B) wild-type IAA17and 
IAA17M2. In the bottom panels, squares are the experimental data, and solid lines 





























Part III. Interaction of Aux/IAA 17 domain III-IV 
and ARF1 domain III-IV 
 
 
Structure PB domain of ARF1 
  
To understand the interaction of ARF1 and Aux/IAA17, ARF1DIII-IV was 
modeled with homology in silica using the SWISS-MODEL automated 
protein structure homology modeling server (http://swissmodel.expasy.org) 
(Figure 22 C D, Figure 23 C D). I set out to solve the solution structure of the 
ARF1 domain III-IV using RDCs data that was employed for ARF5 domain 
III-IV(4CHK). The present structure of ARF5 domain III-IV agrees RDCs 
measured on the ARF1 domain III-IV with an RDC R-factors of 18% (Figure 
23). This result indicated that the backbone structure of ARF1 domain III-IV 
is similar to the ARF5 domain III-IV. Analysis of the homodimer interface 
using PDBePISA (50) (http://pdbe.org/pisa) suggests a total of 28 amino acids 
contacts across interaction interface of ARF5DIII/IV. The residue is involved 
in the acidic interface that are highlighted by blue circle, and basic interface 
that are highlighted by red circle (Figure 21).  Understanding structural 
different of ARF1 and ARF5, I examined the detail of the electrostatic 
potential and hydrophobic contacts of interaction surface between ARF5 
DIII/IV and ARF1 DIII/IV (Figure 22). Both ARF5 DIII/IV and ARF1 
DIII/IV are exhibited similar location of positive and negative surface at the 
interfaces, and hydrophobic region also are located in the same location. 
However, the size of hydrophobic region is different. Based on the ARF1DIII-
IV structure modeling data and crystal structure of ARF5DIII-IV, the size of 
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hydrophobic pocket at negative interface of ARF5 is smaller than ARF1 
(Figure 23 B and D). In addition, the loop size at positive interface of ARF5 is 
also smaller than ARF1 (Fig 23 A and C).  
 
Figure 19. 
Multiple Sequence alignment of DIII/IV of ARF1, ARF5, ARF7, and 
IAA17 
 The residues of homodimeric interface of ARF5 DIII/IV (X-ray structure) are 
indicated in blue (positive interface) and red cycle (negative interface). Purple 




















































Figure 20. Binding interface of ARF5 and ARF1. 
(A)(B) ARF5 structure, (C)(D) ARF1 model. Residues involved interface are 
marked as color. Positive residue is blue. Negative residue is red. Polar residue is 
green. Hydrophobic residue is orange. Charged residue are located in similar 
position on the surface.  
 
B. ARF5 negative  interfaceA. ARF5 positive  interface










Figure 21. Positive and negative interface of ARF5 and ARF1 
 
Negative and positive interface of ARF (A) ARF5 negative interface from structure. 
(B) ARF5 positive interface from structure. (C) ARF1 negative interface from model. 
(D) ARF1 positive interface from model. Positively charged residues represented in 
blue, negatively charged residues represented in red, Polar residues represented in 
green, and hydrophobic residues represented in white. The orientation for the negative 






























Figure 22. Correlation plots between experimental and back-calculated RDCs 



















Interaction between ARF repressor and ARF activator and Aux/IAA 
  
I showed that the interaction between ARF5 activator and 
Aux/IAA17 (KD : 0.07mM) is stronger than homotypic ARF5 (KD : 0.87mM) 
and homotypic Aux/IAA17 (KD : 6.6mM ) in chapter 2. Other studies shown 
similar binding affinity homodimer of Ps-IAA4 (KD : 6.4mM) and ARF7 (KD : 
0.18mM ) (27, 51). The mutations that prevented the oligomerization of 
ARF1III-IV similarly produced a monomeric form of ARF5III-IV  and 
Aux/IAA17 III-IV . A single mutant, K797A (ARF5M1), K114M (IAA17M1) and 
a double mutant, D847N/D851N (ARF5M2), D183N/D186N (IAA17M2), 
produced monomeric proteins as the same mutation in IAA17. Using ITC, we 
measured the binding affinity of the between ARF1M1 and ARF1M2 
homodimer. I also measured that of the heterodimer between ARF1M1 and 
IAA17M2, in addition to ARF1M1 and ARF1M5. The affinity for the homodimer 
was stronger than both heterodimers, with the KD values measured as 0.24 mM 
for ARF1M1: ARF1M2 complexes (Figs. 23 A, Table 3). Thus, the affinity of 
the homodimer was about 10 times higher than that of the ARF1M1: IAA17M2 
(KD : 2.9mM) heterodimer, and ARF1M1: ARF5M2 (KD : 2.3mM) heterodimer. 
The heterodimer can bind using two different interfaces (ARF1M1: IAA17M2 
and IAA17M1: ARF1M2, ARF1M1: ARF5M2 and ARF5M1: ARF1M2) depending 
on which protein employs the positive interface for the complex formation. I 
measured the binding affinity of the heterodimer in two different ways. When 
ARF1 employs the negative interface for the heterodimer formation, the 
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binding affinity could not be measured by ITC, because it was higher than 100 
mM. 
 
Mapping the basic interface of the IAA17DIII-IV hetero dimer. 
 
To understand the structural basis of the preferential heterodimer 
formation, we compared the binding interface of the repressor-
heterodimer(15N-labeled-IAA17M1:ARF1M2) with that of the activator-
heterodimer(15N-labeled-IAA17M1:ARF1M2) (Figure 24). Large chemical 
shifts perturbation (CSPs) is mainly shown in the β3−β4−α2 region that 
contained Asp183 and Asp187 (Figure 24). The CSP data indicates that 
IAA17 M1 used largely the similar binding interface of the heterodimer 
formation with ARF5 M2 and ARF1 M2. Therefore, electrostatic interaction 
(Lys of basic interface, Asp of acidic interface) induces the binding of homo-
hetero formation. The refined thermodynamic and structural analysis of ARF5 
DIII/IV, ARF7 DIII/IV interface showed that Domain III/IV dimerization is not 
only driven by electrostatic force between the invariant lysine and main 
cluster of acidic residue in PB domain but also hydrogen bonding and 
hydrophobic contact (52) (Figure 21, Figure 22). The modeling structure of 
ARF1 positive interface and ARF5 negative interface shows static hindrance 






ARF1 domain III/IV mutation for heterodimer 
 
The positive interface of ARF1(repressor) has one more residue (Ala 548 
ARF1) in loop. The negative interface of ARF activator has highly conserve 
residue in hydrophobic pocket (valine, leucine).  I mutated deletion Ala 548 
and Q545T in positive interface of ARF1 and M597V and M598L in negative 
for understanding binding preference of ARF1.   
The binding heat of heterodimer (ARF1M2: ARF5M1) and heterodimer 
(ARF1M2: IAA17M1) formation is not detected by ITC, that employed positive 
interface of ARF1. The ARF1M2D548AQ545T is shown similar binding affinity of 
hetero dimer formation (ARF1M1:ARF5M2, ARF1M1: IAA17M2) (Figure 26 B).   
To confirm the contribution of Ala548 residue in ARF1 to 
heterodimer formation (ARF1M2: IAA17M1), I mutated ARF5M2ins804A and 
ARF1M1 M597LM598V and assessed ARF1, ARF5, and IAA17 binding by ITC. 
The affinity of the ARF5M2intA804 with ARF1M1 was similar values of ARF1 
homodimer formation. When ARF1M1 M597LM598V employs the negative 
interface for the homodimer formation, the binding affinity could not be 









Figure 23. KD of the homodimer and heterodimer formation of IAA17IIIIV, 
ARF5IIIIV and ARF1 IIIIV. 
Integrated heats of injection (solid squares) and the least squares fit curves (black 
line), derived from a simple one-site binding model for the titration between  
(A) ARF1M1 and ARF1M2 (B) ARF5M1 and IAA17M2 (C) ARF1M1 and ARF5M2 (D) 








Figure 24. Heterodimer basic interface of Aux/IAA17 domain III-IV 
Weighted average 1HN/
15N chemical shift perturbation (CSP=([(HN)
2 + 
(N)
2/25]/2)1/2) as a function of residue number upon heterodimer 
formation. Residues with > 0.1 are shown in yellow with the conserved 























Figure 25. Domain III-IV structure of ARF5(A) homodimer and 
ARF1(B) heterodimer.  
   
 

















Figure 26. KD of interface mutation on ARF1DIII-IV positive interface 
(A) The binding affinity of ARF1M2 using positive interface, derived from a 
simple one-site binding model titration between ARF1M2 and ARF1M1, 
ARF5M1, and IAA17M1. The binding heat only detected from homodimer 
formation.  
(B) The hydrophobic loop of ARF1M2(Q545T DelA548) is smaller than ARF1M2. 










Figure 27. KD of interface mutation on ARF1DIII-IV negative interface 
and ARF5DIII-IV positive interface. 
(A) The binding affinity of ARF5M2(intA804) using positive interface, the 
binding affinity is reduced for heterodimer.    
(B) The hydrophobic loop of ARF1M2(Q545T DelA548) is smaller than ARF1M2. 






-     +
ARF1M 1    ARF5M2 insA804
KD = 0.88 ± 0.2μM
-     +
ARF5M 1     ARF5M 2 insA804
KD = 8.20 ± 1.4μM 
-     +
IAA17M 1     ARF5M2 insA804
KD = 7.75 ± 1.4μM 
-     +
ARF1M 5     ARF5M 2 insA804
KD = 2.5 ± 0.61μM
ARF1 M1 M 597L  M 598V  
M597L
M598V
-                +
ARF1M1 M597L  M 598V               ARF1M2
-     +
ARF1M1 M597L  M 598V  ARF5M2
KD = 3.03 ± 0.86μM 
-     +
ARF1M1 M597L  M 598V   ARF5M 2 insA804
KD = 2.5 ± 0.61μM
-     +
ARF1M1 M597L  M 598V   IAA17M 2 











Table 3. Thermodynamic parameters for the homodimer and 
heterodimer formation between domains III-IV of ARF1, IAA17 and 

























Description KD (μM) DG (kcal/mol) DH (kcal/mol) -TDS (kcal/mol) 
 ARF1M1  + ARF1M2 0.25 ± 0.05 -9.0    -3.3 ± 0.0 19.1   
 ARF1M1  + IAA17M2 2.31 ± 0.57 -7.7    -9.0 ± 0.1 -4.4   
 ARF1M1  + ARF5M2 2.90 ± 0.69 -7.6    -4.6 ± 0.3   9.8   
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Figure 28. A model of transcriptional control from the interaction between IAA 
and ARF 
In the presence of auxin, IAA is degradation and ARF activator forms an active 
oligomer to turn on the gene expression. In the absence of auxin, IAA and ARF 
activator form hetero-oligomers for transcriptional repression. In addition, association 













The interplay between ARF and IAA repressor is the most important 
regulation of auxin-response gene expression. Recent investigations have 
focused on transcriptional response to auxin, however, the structural 
mechanisms were poorly understood. I have shown that IAAIII-IV and 
ARFIII-IV have the same PB1-like b-grasp scaffolds. The difference is that 
IAAIII-IV has the long insert sequence (a dynamic helical conformation).  
The role of this dynamic helix of IAA17 is still unclear in the role of 
homodimer (IAA17:IAA17) and heterodimer (IAA17:ARF5). The truncation 
of the dynamic helix did not perturb neither the folding nor the 
oligomerization. The path from auxin signal perception to altered gene 
expression has a lot of key components. The dynamic helix can interact with 
other key proteins the pathway. An impact of the dynamic helix on the 
binding specificity of IAA17 requires careful examination in systematic 
binding studies. 
The chemical shift perturbation profiles indicate that IAA17 employs 
similar binding interface of the IAA-IAA, the IAA-ARF (repressor) and , 
IAA-ARF (activator) interaction. The binding interfaces were consistent with 
the oligomer in the crystal structure (ARF5:4CHK, ARF7:4nj6) and CSP 
result of PsIAA4. It suggests that the homo- and hetero-oligomers would 
extend in a similar arrangement. The single and double mutations in this study 
abolished the oligomerization of IAA, ARF(repressor), and ARF(activator). 
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The key charge residues and distribution at the interfaces are essential for the 
association.  
The binding affinity of the heterodimer (IAA17:ARF5) indicates that the 
charge modulation at the interaction surface can be a general strategy to head-
tail between IAA and ARF activator family proteins. Although electrostatic 
contacts are critical for domain III-IV oligomerization, the binding preference 
of IAA17 has different role between IAA and ARF activator and ARF 
repressor. The ARF1(repressor) model is predicted to be highly similar to the 
ARF5(activator). The key residues are also highly conserved in negative and   
positive interface. By contrast, the binding affinity of heterodimer 
(IAA17:ARF1) of IAA17 is weaker than heterodimer IAA17:ARF5 and 
homodimer (ARF1:ARF1). ARF1 (repressor) has one more hydrophobic 
residue in basic interface. The acidic interface of ARF1 consists of methionine 
instead of valine in ARF activator. These modifications are shared in most of 
ARF repressor and could reduce the capacity of ARF repressor to interact 
with ARF activators and IAAs. 
    
 The auxin-signaling model described a Aux/IAA protein interacting with a 
ARF protein in low concentration of auxin. In vivo, IAA and ARF family 
concentrations are not known, but local concentration can be rised when auxin 
regulated transcription in nucleus. The highly expressed IAA and ARF family 
that can lead to the formation of high-order oligomers. The binding affinity is 
notable that binding favors are the heterodimer formation over individual 
homodimers. The repression of ARF is a thermodynamically downhill process 
 
 ５８
by IAA. When auxin is low concentration in nucleus, formation of the higher-
affinity hetero-oligomer is preferred for transcriptional repression. The auxin 
promotes degradation of IAA releasing ARF activator. The equilibrium shift 
re-establishes ARF5 homo-oligomers to resume transcriptional activation. 
However, the binding favor is the homodimer in case of ARF1(repressor). 
This   binding favor suggests that ARF repressor is auxin independent and 
might simply compete with ARF activators for binding to the promoter of 
auxin-inducible genes without forming heterodimer with Aux/IAA.   
Taken together, IAA17 forms a tight heterodimer with ARF5(activator) by 
both positive and negative interfaces. It can insert itself into the ARF5 
oligomer to form a hetero-oligomer (Figure 28). ARF1(repressor) forms a 
tight homodimer by both positive and negative interfaces of it’s own. In this 
model, the transcriptional repression can be achieved by 1) homo-oligomer of 
ARF1   and 2) by hetero-oligomer of ARF5 with IAA. ARF5 keeps high 
local concentrations by forming hetero-oligomers, so that functional ARF 
oligomers can rapidly form upon IAA degradation and promptly express 
auxin-response genes. The subunit exchange (driven by thermodynamic 
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국문 초록  
 
식물 호르몬 auxin 은 식물의 생장, 발달, 분화 등에 광범위하게 
작용하여 식물생리현상을 좌우하는 가장 주된 역할을 담당하고 있다. 
100 여 년 전, 식물의 굴광성이 auxin 이라는 화합물에 의해서 유발된다는 
사실이 알려진 이후, auxin 의 효과는 다양한 유전학 및 식물분자생물학 
연구 결과로부터 auxin 에 의해 조절되는 유전자 발현에서 기인하는 
것으로 밝혀지고 있다. Auxin 에 의한 유전자의 발현은 전사 인자 ARF 
(Auxin-response factor)와 전사조절인자 IAA (Aux/IAA)의 상호작용으로 
조절된다. ARF 는 식물 내 특정 유전자의 발현을 유발하거나 억제하는 
것으로 알려져 있고, IAA 는 이 ARF 와 결합하여 그 기능을 저해한다. 세포 
내로 auxin 이 유입되면 IAA 는 F-box 단백질 SCFTIR1 과 결합하여 
proteasome-mediated protein degradation pathway 를 통하여 분해되고, 
이로부터 해방된 ARF 는 본래의 유전자 발현 기능을 수행하게 된다. 애기 
장대 식물 내에는 29 종의 IAA 와 23 종의 ARF 단백질이 존재하며 이들의 
상호작용 네트웍을 통하여 생장, 발달, 분화가 조절된다. 이와 같이 IAA 와 
ARF 의 상호작용이 auxin-response 전사 제어의 중심에 있음에도 불구하고, 
그 구조적 메커니즘은 잘 밝혀져 있지 않다. 보고된 바로 ARF 와 
Aux/IAA 는 domain III-IV 라고 불리는 공통된 단백질 상호작용 모티브를 
이용하여 상호작용한다. 전사 인자와 억제 인자는 각 따로 있을 경우 본 
domain III-IV 를 매개로 homo-oligomer 를 형성하고, 두 단백질이 함께 
있을 경우에는 hetero-oligomer 로 중합체 조성을 바꾸며 유전자 발현을 
억제하는 것으로 예측되었다.  
 
 ６７
 본 연구에서는 nuclear magnetic resonance(NMR) 분광학을 이용하여 
전사억제인자인 Aux/IAA17 의 domain III-IV 의 삼차원 수용액 구조를 
규명하였으며, 이는 기존에 보고되었던 PB1 domain 의 구조와 
유사한구조로 보고하였다. 또한 이 단백질이 ARF5 ( transcription activator) 
의 domain III-IV 와 결합하는 경우 self-oligomer 에 비하여 결합력이 훨씬 
증가한다는 사실을 보고하였다. 이러한 결합력에 차이를 보이는 원인은 
전하를 가지는 표면의 전하 분포와 밀집도 에서 오는 것으로 나타나며, 
결합 부위에서 반대되는 전하 배치의 상보성이 중요한 요인으로 작용하는 
것을 보였다. 마지막으로, Aux/IAA17 의 domain III-I 를 통한 상호작용 
여부가 논란이 되었던 ARF1(transcription repressor) 의 domain III-IV 와 
결합하는 경우  ARF1 self-oligomer 에 비하여 결합력이 훨씬 약하다는 
사실을 실험을 통하여 확인하였다. 이러한 결합력에 차이를 보이는 원인은 
ARF1 repressor 의 binding interface 의 형태적인 면에서 기인한다 할 수 
있다. ARF1 의 domain III-IV 간의 self-oligomer 의 결합력이 hetero-
oligomer 에 비해 강한 결합력을 보이는 결과를 바탕으로 ARF repressor 의 
경우 Auxin 이 유전자 전사 조절에 관여하지 않을 것을 의미한다. 가장 
강한 결합력을 보인 ARF5 와 Aux/IAA17 간의 상호작용으로 Auxin 에 의한 
유전자 전사가 억제 되는 것이며, ARF1 과 같은 repressor 의 경우 
Aux/IAA17 과의 domain III-IV 통한 상호작용은 없이 ARF1 repressor 의 
self-oligomer 로 유전자 전사가 억제 되는 것으로 실험을 통하여 
확인하였다. 
 
 
 
